Lung Cancer (LNCR)

肺癌(来自ICD-11)

别称:

Lung Carcinoma

Non-Small Cell Lung Carcinoma

Nsclc

Adenocarcinoma of Lung, Response to Tyrosine Kinase Inhibitor in

Lung Cancer, Protection Against

Adenocarcinoma of Lung, Somatic

Lung Cancer, Susceptibility to

Lung Non-Small Cell Carcinoma

Non-Small Cell Lung Cancer

Malignant Neoplasm of Lung

Nonsmall Cell Lung Cancer

Alveolar Cell Carcinoma

Carcinoma of Lung

Lung Neoplasms

Lung Neoplasm

Nonsmall Cell Lung Cancer, Response to Tyrosine Kinase Inhibitor in

Nonsmall Cell Lung Cancer, Susceptibility to

Nonsmall Cell Lung Cancer, Somatic

Primary Malignant Neoplasm of Lung

Bronchioloalveolar Adenocarcinoma

Carcinoma, Non-Small-Cell Lung

Carcinoma Non-Small Cell Lung

Cancer, Lung, Non-Small Cell

Lung Cancer, Resistance to

Malignant Tumor of Lung

Adenocarcinoma of Lung

Lung Malignant Tumors

Respiratory Carcinoma

Lung Cancer, Somatic

Malignant Lung Tumor

Pulmonary Carcinoma

Pulmonary Neoplasms

Cancer of Bronchus

Cancer of the Lung

Lung Malignancies

Pulmonary Cancer

Neoplasm of Lung

Lung Carcinomas

Cancer of Lung

Lung Cancers

Cancer, Lung

Cancer Lung

Lncr

加入收藏

基础信息

疾病表征

基因 & 突变

靶点药物

疾病模型

文献报道

肺癌，又称肺癌，与肺癌易感性3和小细胞肺癌有关，症状包括咳嗽、胸痛和体重减轻。与肺癌相关的重要基因是BRAF（B-Raf原癌基因，丝氨酸/苏氨酸激酶），其相关通路/超级通路包括先天免疫系统和传染病。在该疾病的背景下，已提到的药物有双氯芬酸和胺碘酮。附属组织包括肺和脑，相关表型为肺腺癌和非小细胞肺癌。

查看原文参与反馈